Breakthru Medicine: Valuation, Funding & Investors
Phoenix, Arizona 86004, UShttps://www.breakthrumed.com/
Breakthru Medicine is a private biotechnology company developing disruptive therapeutic modalities for cancer patients, focusing on tumor-agnostic targeted therapies. The company’s platform spans small molecules, molecular glues, and next-generation antibody-drug conjugate payloads aimed at expanding the druggable universe for hard-to-drug targets.
Leadership & Board
- Current Number of Employees
- 17
- Current LinkedIn Followers
- 858
Latest Estimated Valuation
- Total Amount Raised
- $60M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $60M
- Latest Funding Round
- Series A
Employee Trend
Breakthru Medicine had 17 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
17Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Breakthru Medicine had 858 followers as of November 9, 2026. The number of followers increased by 6 (0.70%) week-over-week.
858Latest Followers Count
6(0.70%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 29, 2026 | Series A | $60.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Dave Morehead | Series A |
| Fred Eshelman | Series A |
| Mark Gergen | Series A |
Similar Companies
A snapshot of private companies similar to Breakthru Medicine, helping you discover and navigate related company profiles.
Related News and Analysis
